Menthol, Inflammation, and Nicotine Transition Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-85
SponsorRosalind Franklin University of Medicine and Science
About this trial
This study will focus on examining the potential impact of menthol flavoring in cigarettes on biomarkers of systemic inflammation as a subclinical indicator of cardiovascular disease risk.
Eligibility criteria
Qualifiers
Men and women between 21-85 years old
Currently uses menthol cigarettes
Daily smoking rate of ≥5 cigarettes/day for ≥1 year
Currently own and regularly use an iOS/Android smartphone device able to download the LifeData application
Disqualifiers
Currently pregnant or breastfeeding
Actively trying to quit smoking
Current heavy alcohol use
Frequent use of non-menthol cigarettes, other smoking products, or illicit substances
Trial design
Treatments tested in this trial
- Cigarette Type Switching
Treatment groups
68 Participants
are divided into 1 treatment groupLocations
1Rosalind Franklin University of Medicine and Science60064, North ChicagoIllinois, United States
Sponsors and collaborators
Rosalind Franklin University of Medicine and Science
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Source ClinicalTrials.gov